Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

18.35 -0.39 (-2.08%)
Streaming Delayed Price Updated: 3:48 PM EDT, Sep 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,438,714
Open 18.76
Bid (Size) 18.35 (400)
Ask (Size) 18.36 (400)
Prev. Close 18.74
Today's Range 18.33 - 18.96
52wk Range 7.065 - 20.05
Shares Outstanding 122,816,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Healthcare Stocks We’re Skeptical Of
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva... 
Via StockStory
News headline image
3 Reasons NEO is Risky and 1 Stock to Buy Instead
What a time it’s been for NeoGenomics. In the past six months alone, the company’s stock price has increased by a massive 138%, reaching $19.30 per share. Th... 
Via StockStory
Topics Bankruptcy Supply Chain

Performance

YTD
+56.0%
+56.0%
1 Month
+2.5%
+2.5%
3 Month
+25.8%
+25.8%
6 Month
+147.3%
+147.3%
1 Year
+136.2%
+136.2%

More News

Read More
News headline image
NeoGenomics Highlights NGS, MRD Growth Strategy at Morgan Stanley Conference ↗
Via MarketBeat
News headline image
1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down
Via StockStory
Topics Economy
NeoGenomics (NASDAQ:NEO): Quality Stock After Q2 Earnings Beat and Raised Guidance ↗
Via Chartmill
Topics Earnings
News headline image
A Look Back at Testing & Diagnostics Services Stocks’ Q2 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack
Via StockStory
News headline image
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring
From NeoGenomics, Inc.
Via Business Wire
News headline image
3 Unprofitable Stocks Walking a Fine Line
Via StockStory
News headline image
3 Stocks Under $50 with Open Questions
Via StockStory
News headline image
3 Healthcare Stocks with Questionable Fundamentals
Via StockStory
News headline image
Why NeoGenomics (NEO) Stock Is Up Today
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
Via StockStory
News headline image
NeoGenomics Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
NeoGenomics’s (NASDAQ:NEO) Q2 CY2026: Beats On Revenue
Via StockStory
News headline image
NeoGenomics Reports Second Quarter 2026 Results
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics (NEO) Q2 Earnings Report Preview: What To Look For
Via StockStory
Topics Artificial Intelligence
News headline image
1 Momentum Stock with Solid Fundamentals and 2 We Avoid
Via StockStory
News headline image
NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS
From NeoGenomics, Inc.
Via Business Wire
News headline image
3 Small-Cap Stocks with Questionable Fundamentals
Via StockStory
News headline image
NeoGenomics (NEO) Stock Trades Up, Here Is Why
Via StockStory
Topics Intellectual Property Lawsuit
News headline image
NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
A Look Back at Testing & Diagnostics Services Stocks’ Q1 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack
Via StockStory
News headline image
NeoGenomics Appoints Carolyn Starrett to its Board of Directors
From NeoGenomics, Inc.
Via Business Wire

Frequently Asked Questions

Is NeoGenomics, Inc. - Common Stock publicly traded?
Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
What exchange does NeoGenomics, Inc. - Common Stock trade on?
NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
What is the current price of NeoGenomics, Inc. - Common Stock?
The current price of NeoGenomics, Inc. - Common Stock is 18.35
When was NeoGenomics, Inc. - Common Stock last traded?
The last trade of NeoGenomics, Inc. - Common Stock was at 09/30/26 03:48 PM ET
What is the market capitalization of NeoGenomics, Inc. - Common Stock?
The market capitalization of NeoGenomics, Inc. - Common Stock is 2.25B
How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
NeoGenomics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.